Key Takeaways
- Shares of IREN jumped approximately 6% during Monday’s premarket session, rebounding from Thursday’s 10.39% decline
- AI company Anthropic is seeking proposals for 1.4GW of data center infrastructure in Australia, a project estimated between $12 billion and $15 billion
- Wall Street analysts maintain a consensus Buy recommendation with a mean price target of $81.75 — significantly above present levels
- Pictet Asset Management increased its position in IREN by 349.3% during the first quarter, purchasing an additional 99,384 shares
- Questions remain about corporate governance following an $800M co-CEO equity package and sports sponsorship announcement
Shares of IREN rebounded approximately 6% in Monday’s premarket hours, reaching roughly $41.05, after experiencing a sharp 10.39% decline during Thursday’s trading session.
The driver behind the move? According to Street Talk, a column in The Australian Financial Review, Anthropic has launched a confidential bidding process for a minimum of 1.4 gigawatts of data center infrastructure in Australia. Industry sources estimate the total investment at $12 billion to $15 billion.
IREN has been identified as one of several companies on the competitive shortlist. Other contenders include CDC Data Centres, AirTrunk, NextDC, and Stack Infrastructure.
Anthropic’s requirements call for at least 1 gigawatt to be operational by late 2027. Rather than awarding the entire contract to one vendor, the AI firm may distribute the work among multiple providers.
According to industry sources cited in the report, Infratil-backed CDC Data Centres is positioned to secure the largest portion should Anthropic decide to partition the contract.
This development provided a welcomed lift for IREN at a moment when bitcoin mining operations pivoting to AI infrastructure have faced headwinds from escalating costs, intensifying competition, and substantial capital expenditure demands.
Wall Street’s Perspective
Despite recent volatility, analyst sentiment toward IREN remains decidedly optimistic. The consensus rating stands at Buy, with a mean price objective of $81.75 — representing roughly a 100% premium to current trading levels.
Jefferies initiated coverage on June 18 with a Buy recommendation and $79 price target. Macquarie maintained its Outperform stance with a $90 objective on June 4. B. Riley Securities elevated its target to $96 while reaffirming its Buy rating that same day.
Bernstein holds a $100 price target alongside a Buy rating, citing IREN’s data center expansion strategy as the primary growth catalyst.
Canaccord Genuity lifted its price objective from $70 to $79 on June 3, maintaining a Buy rating. HC Wainwright increased its target to $85 in May.
The company is slated to announce quarterly results on August 27. Consensus estimates project a loss of $0.38 per share on revenues of $165.16 million.
Those figures would represent improvement from the year-ago period, which saw a loss of $0.66 per share and revenue of $187.30 million.
Corporate Governance Issues Create Headwinds
Not all recent developments have been favorable. IREN’s board approved an $800 million equity compensation arrangement for its co-chief executives, while simultaneously announcing a sponsorship agreement with the Golden State Warriors.
These decisions triggered backlash from individual investors and market analysts, prompting scrutiny regarding capital deployment priorities and potential shareholder dilution. Adding to the negative sentiment, a board member recently divested 11,958 shares.
Nevertheless, institutional appetite has strengthened. Pictet Asset Management expanded its holdings by 349.3% in the first quarter, acquiring 99,384 additional shares to reach a total position of 127,835 shares valued at approximately $4.38 million.
Multiple other institutional investors established new positions in IREN during the fourth quarter, including North Star Investment Management, Clearstead Trust, and Aventura Private Wealth.
From a chart perspective, IREN continues trading beneath all major moving averages. The stock sits 23.2% under its 20-day simple moving average and 24.9% below its 50-day SMA. Immediate resistance appears near $45.50, while support is established around $36.
The stock’s 52-week range spans from $14.72 to $76.87, with a current market capitalization of $13.87 billion.





